CALC vs PODD · $22.5M cap vs P/E 34, rev $2.07B
CalciMedica, Inc. Common Stock (CALC) versus Insulet Corporation (PODD) — a side-by-side from cached financials, not a winner call.
CalciMedica, Inc. Common Stock (CALC) is a biotechnology company listed on US.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
CALC does not have a complete income-statement cache yet.
Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
CALC currently screens at market cap $22.5M. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Not investment advice. Open the CALC and PODD stock pages for the full models.
Not investment advice.